Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lexin Wang

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 23, 2016
The stimulatory effects of eNOS/F92A-Cav1 on NO production and angiogenesis in BMSCsPeng Xia, Hai-Ying Chen, Shuang-Feng Chen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 8, 2023
Nanoparticle albumin-bound paclitaxel-based neoadjuvant regimen: A promising treatment option for HER2-low-positive breast cancerWenjie Shi, Xinyu Wan, Ye Wang, et al.
Acta Biochimica Et Biophysica Sinica|March 5, 2024
The mechanism by which piR-000699 targets SLC39A14 regulates ferroptosis in aging myocardial ischemia/reperfusion injuryHongyang Chi, Yue'e Chai, Lingju Ma, et al.
NPJ Digital Medicine|December 26, 2025
Artificial intelligence-based personalized treatment strategies for unresectable hepatocellular carcinoma: integrating HSP90α for prognosis and survival predictionKe Su, Xin Liu, Xuelian Wang, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 23, 2016
The stimulatory effects of eNOS/F92A-Cav1 on NO production and angiogenesis in BMSCsPeng Xia, Hai-Ying Chen, Shuang-Feng Chen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 8, 2023
Nanoparticle albumin-bound paclitaxel-based neoadjuvant regimen: A promising treatment option for HER2-low-positive breast cancerWenjie Shi, Xinyu Wan, Ye Wang, et al.
Acta Biochimica Et Biophysica Sinica|March 5, 2024
The mechanism by which piR-000699 targets SLC39A14 regulates ferroptosis in aging myocardial ischemia/reperfusion injuryHongyang Chi, Yue'e Chai, Lingju Ma, et al.
NPJ Digital Medicine|December 26, 2025
Artificial intelligence-based personalized treatment strategies for unresectable hepatocellular carcinoma: integrating HSP90α for prognosis and survival predictionKe Su, Xin Liu, Xuelian Wang, et al.
Pageof 12